Tag: Irukandji Syndrome
Phebra to spearhead clinical trial for Irukandji Syndrome antidote
Australian pharmaceutical company Phebra in collaboration with distinguished experts from around North Queensland will be working on a new clinical trial to test the...
Featured Article
The future of sports manufacturing: Inside M2M Group’s AI-powered strategy
As the sports manufacturing industry evolves, artificial intelligence (AI) is emerging as a critical catalyst for innovation and efficiency.
